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Unraveling which proteins and post-translational modifications (PTMs) affect bacterial
pathogenesis and physiology in diverse environments is a tough challenge. Herein,
we used mass spectrometry-based assays to study protein phosphorylation and
glycosylation in Ehrlichia ruminantium Gardel virulent (ERGvir) and attenuated (ERGatt)
variants and, how they can modulate Ehrlichia biological processes. The characterization
of the S/T/Y phosphoproteome revealed that both strains share the same set of
phosphoproteins (n = 58), 36% being overexpressed in ERGvir. The percentage of
tyrosine phosphorylation is high (23%) and 66% of the identified peptides are multi-
phosphorylated. Glycoproteomics revealed a high percentage of glycoproteins (67%
in ERGvir) with a subset of glycoproteins being specific to ERGvir (n = 64/371) and
ERGatt (n = 36/343). These glycoproteins are involved in key biological processes such
as protein, amino-acid and purine biosynthesis, translation, virulence, DNA repair, and
replication. Label-free quantitative analysis revealed over-expression in 31 proteins in
ERGvir and 8 in ERGatt. While further PNGase digestion confidently localized 2 and
5 N-glycoproteins in ERGvir and ERGatt, respectively, western blotting suggests that
many glycoproteins are O-GlcNAcylated. Twenty-three proteins were detected in both
the phospho- and glycoproteome, for the two variants. This work represents the first
comprehensive assessment of PTMs on Ehrlichia biology, rising interesting questions
regarding ER–host interactions. Phosphoproteome characterization demonstrates an
increased versatility of ER phosphoproteins to participate in different mechanisms.
The high number of glycoproteins and the lack of glycosyltransferases-coding genes
highlight ER dependence on the host and/or vector cellular machinery for its own
protein glycosylation. Moreover, these glycoproteins could be crucial to interact and
respond to changes in ER environment. PTMs crosstalk between of O-GlcNAcylation
and phosphorylation could be used as a major cellular signaling mechanism in ER.
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As little is known about the Ehrlichia proteins/proteome and its signaling biology,
the results presented herein provide a useful resource for further hypothesis-driven
exploration of Ehrlichia protein regulation by phosphorylation and glycosylation events.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium with the data set identifier PXD012589.
Keywords: Ehrlichia ruminantium, phosphoproteins, S/T/Y phosphorylation, N-glycoproteins, O-GlcNAcylated
proteins, bacteria physiology, pathogenesis
INTRODUCTION
Ehrlichia species are Gram-negative obligate intracellular
bacteria, transmitted by ticks. They belong to the
Anaplasmataceae family in the order Rickettsiales.
Anaplasmataceae includes the genera Anaplasma, Neorickettsia,
and Wolbachia. The Ehrlichia genus includes E. chaffeensis (the
causative agent of human monocytic ehrlichiosis, HME) and
E. ewingii (which causes E. ewingii ehrlichiosis). Other species
within this genus include E. canis, Panola Mountain Ehrlichia,
Ehrlichia muris-like agent (EMLA), and Ehrlichia ruminantium
(ER), which are predominantly veterinary pathogens but may
occasionally infect humans (Maeda et al., 1987; Allsopp et al.,
2005; Reeves et al., 2008; Pritt et al., 2011). Three news species of
cattle-related Ehrlichia spp. (closely related to E. canis) have been
recently reported (Cabezas-Cruz et al., 2014). At the moment,
there is no effective commercial vaccine available for any of the
Ehrlichia species, with impact in human and veterinary health.
Avoidance of tick bites remains the mainstay of prevention
(Thomas et al., 2016).
Infection with Ehrlichia species in mammalian cells begins
with the intracellular uptake of the infectious extracellular form
of the organism, the EB or DC. After EB/DC endocytosis, the
bacterium replicates and matures to form a RB or RC and
then morula before redifferentiating into EB/DC that leaves
the infected host cell after lysis to spread infection (McClure
et al., 2017). During this process, Ehrlichia utilizes many evasion
mechanisms including suppression of apoptosis of host cells,
modulation of chemokine and cytokine responses, and down-
regulation of host pattern recognition receptors that might
enable clearance of the infection (Thomas, 2016). Ehrlichia
life cycle in the tick vector is still not fully elucidated. To
adapt and survive to the different growth conditions both
in mammalian and arthropod hosts, the bacterium relies on
differential gene expression, but also on the modification of
proteins and other molecules.
Post-translational modifications are one of the most important
mechanisms for activating, changing, or suppressing protein
functions, being widely used by pathogens to interact with their
hosts (Ribet and Cossart, 2010; Prabakaran et al., 2012; Beltrao
Abbreviations: DC, dense core; 2DE, bidimensional electrophoresis; EBs,
elementary bodies; ER, Ehrlichia ruminantium; ERGatt, Ehrlichia ruminantium
Gardel attenuated strain; ERGvir, Ehrlichia ruminantium Gardel virulent strain;
FASP, filter-aided sample preparation; Hpi, hours post-infection; LFQ, label-free
quantification; nanoLC, nano-scale liquid chromatography; nLC–MS/MS, nano-
scale liquid chromatography–tandem mass spectrometry; PTM, post-translational
modification; RBs, reticulate bodies; RC, reticulate core; RT, room temperature;
S/T/Y, serine/threonine/tyrosine.
et al., 2013; Salomon and Orth, 2013; Cain et al., 2014; Ravikumar
et al., 2015; Müller, 2018). Presently, over 450 different PTMs are
identified (including phosphorylation, glycosylation, acetylation,
succinylation, pupylation, etc.) expanding the diversity of the
proteome enormously (Prabakaran et al., 2012; Striebel et al.,
2014; Pisithkul et al., 2015; Singhal et al., 2015; Mijakovic et al.,
2016; Eichler and Koomey, 2017; Christensen et al., 2018; Gaviard
et al., 2018). These PTMs are not genetically encoded and they
can have many different consequences for the affected proteins
and the cellular processes they are involved in Prabakaran
et al. (2012). Phosphorylation is one of the most studied PTMs
in bacteria, being related to cell signaling (Mijakovic et al.,
2016). Glycosylation is the most abundant and diverse form of
modification, impacting protein folding, trafficking, processing,
stability, biological activity (Eichler and Koomey, 2017), and
bacterial pathogenesis (Poole et al., 2018).
Different types of PTMs have been reported in Ehrlichia.
Inside the host cells, E. chaffeensis immunoreactive tandem
repeat proteins (TRPs) TRP47 and TRP75 and E. canis TRP95
were shown to be tyrosine phosphorylated, presumably by host
tyrosine kinases (Wakeel et al., 2010; McBride and Walker,
2011). Luo et al. (2017) revealed that E. chaffeensis TRP120 can
exploit host SUMOylation system during the infection process in
order to establish its intracellular niche. Other Ehrlichia proteins
involved in host immune response such as the immunodominant
28 kDa outer membrane proteins (p28-Omp) in E. chaffeensis and
E. canis can be modified by phosphorylation and glycosylation
(Ganta et al., 2009). Map-1, the major antigenic protein in ER
and homologous to p28-Omp, was also found to be glycosylated
(Postigo et al., 2008). Faburay et al. (2017) recently showed that
such PTMs can have a significant impact for the development of
effective vaccine. Indeed, the production of subunit vaccine based
on glycosylated Map-1 recombinant protein was able to induce
a specific humoral and Th1 type T-cell responses against ER in
sheep, after vaccination (Faburay et al., 2017).
Nevertheless, all of these studies are focused on a limited
number of already identified proteins. To understand the link
between protein phosphorylation/glycosylation and bacterial
adaptation and survival, it is important to have a global view
of the PTMs events taking place at a given time, under specific
conditions. In 2015, our group showed on ER EBs from both
virulent and attenuated variants, that 85% of the identified
proteins were present in more than one proteoform, suggesting
that PTMs are important in ER biology (Marcelino et al., 2015).
Bioinformatics analyses revealed that some proteoforms of the
most abundant proteins Map-1 and Porin ERGA_CDS_05140
were N-glycosylated proteins (Marcelino et al., 2015).
Frontiers in Microbiology | www.frontiersin.org 2 March 2019 | Volume 10 | Article 450
fmicb-10-00450 March 15, 2019 Time: 11:16 # 3
Marcelino et al. Modulation of E. ruminantium Biology by PTMs
Herein, using mass-spectrometry-based assays, we focused on
the most common PTMs – phosphorylation and glycosylation –
to explore how PTMs could modulate ER biological processes,
including pathogenesis. For this, we characterized the proteome,
the S/T/Y phosphoproteome, and the glycoproteome of ER
Gardel variants with different levels of virulence in vivo and
different growth kinetics in vitro (Marcelino et al., 2015). Briefly,
attenuated ER Gardel variant (ERGatt) induces mild clinical signs
(hyperthermia) on naïve goats and strong protective immune
response after challenge, whereas in vitro, the life cycle of ERGatt
is shorter (96 hpi) than for the virulent variant (ERGvir, 120 hpi).
For virulent and attenuated variants, cell lysis occurs with the
release of infectious EBs in vitro (Marcelino et al., 2015). In
this work, we used purified extracellular and infectious EBs
from virulent and attenuated ER Gardel variants and optimized
existing enrichment protocols for glycoproteins [using Ultralink
hydrazide (ULH) resin through the oxidation and non-oxidation
of sugars moieties] and phosphopeptides [using titanium
dioxide (TiO2) beads] detection, followed by mass spectrometry
analysis for protein identification. Phospho- and glycoproteins
differentially detected in both virulent and attenuated variants are
also discussed, as these could be key elements in the interactions
with the host cell, and therefore represent interesting targets to
interfere with the ER infectious process.
MATERIALS AND METHODS
Bacterial Strains
Ehrlichia ruminantium Gardel virulent strain (passages 17, 19,
and 24) and ERGatt (passages 240, 242, and 244) variants were
grown in bovine aortic endothelial cells (BAECs), as described
elsewhere (Marcelino et al., 2015). When 80% cell lysis was
observed, infectious and extracellular EBs were harvested and
then used to (i) infect a new confluent monolayer of BAEC or
(ii) to be purified using a multistep centrifugation methodology
(Peixoto et al., 2007). Purified EBs were stored at −80◦C
with a “Complete EDTA-free” anti-protease cocktail (Roche,
Germany) and anti-phosphatases (Roche, Germany) prior to
proteomic analysis.
Protein Extraction
Elementary bodies protein extracts were prepared using a 2D-
DIGE buffer (7 M urea, 2 M Thio-urea, 4% CHAPS, 30 mM
Tris, pH 8.5) and several cycles of sonication on ice (Vibra
Cell with Microtip W72403, from Sonics and Materials; settings:
30% duty cycle + 2 microtip limit, pulsed duty cycle 20). After
sonication, homogenates were centrifuged at 15,000 × g for
10 min at 4◦C to remove debris. The total amount of protein
per ER sample (three biological replicates per variant) was
quantified using the 2DQuant kit (GE Healthcare) according to
the manufacturer’s instructions.
FASP Protocol for Protein Digestion
Twenty micrograms of ER protein extract (solubilized in 2D-
DIGE buffer) were loaded in the upper part of a microcon-10 kDa
centrifugal unit (Millipore). Proteins were washed three times
with 200 µl of 8 M urea in 50 mM ammonium bicarbonate
(NH4HCO3) using a multistep centrifugation process [at
14,000 × g, RT (25◦C), 20 min]. Flow-through was discarded
after each centrifugation step. Proteins were reduced by adding
100 mM dithiothreitol (DTT), prepared in 8 M urea in 50 mM
NH4HCO3 with 1 h incubation at RT. After three washing
steps with 8 M urea in 50 mM NH4HCO3 (centrifugation at
14,000× g, 20 min, at RT), the proteins were alkylated by adding
50 mM iodoacetamide (IAA) (prepared in 8 M urea in 50 mM
NH4HCO3) at RT and kept in dark for 30 min. Then, proteins
were washed two times with 8 M urea in 50 mM NH4HCO3
and then three times in 50 mM NH4HCO3. The upper filter was
then transferred to a new collection tube. Trypsin gold (Promega,
Madison, WI, United States) was added to the samples at a ratio of
protein:trypsin 30:1, and the samples were incubated at 37◦C for
18 h in 50 mM NH4HCO3. Tryptic peptides were then eluted by
centrifugation at 14,000× g, 10 min, at RT. Formic acid (FA) was
added at a final concentration of 0.5% and peptides were stored
at−20◦C until further use.
Phosphopeptide Enrichment With TiO2
Chromatography
The phosphopeptide enrichment was performed according to
a protocol developed by Thingholm et al. (2006) with some
modifications. Briefly, tryptic peptides (originated from 250 µg
of protein extract per biological replicate) were prepared using
the FASP protocol described above. Peptides were then diluted in
60% acetonitrile (ACN) with 1% trifluoroacetic acid (TFA). TiO2
beads at 0.50 mg/µl were previously equilibrated in 1 M glycolic
acid, 80% ACN, and 1% TFA. To allow an effective peptide
binding to TiO2 beads, 0.6 mg TiO2 per 100 µg of peptides
was used. Solution was incubated during 20 min at RT, with
end-over-end rotation, to avoid loss of specificity. Solution was
centrifuged in a bench top centrifuge at max speed (15,600 × g,
2 min, RT), and supernatant containing non-phosphorylated
peptides was discarded.
TiO2 beads with phosphopeptides were loaded on previously
prepared in-house constructed stage tips (made using high
performance C18 extraction disks into pipette tips). After
two successive washes with 60% ACN and 1% TFA, bound
phosphopeptides were eluted first with 5% NH4OH and then
with 10% NH4OH with 25% ACN. Eluted phosphopeptides were
evaporated, resuspended in 0.1% FA, and stored at −20◦C until
further analysis.
Glycoprotein Enrichment With Ultralink
Hydrazide Resin
Selective enrichment of glycoproteins was performed using ULH
resin according to a protocol developed by Chen et al. (2016),
with some modifications. As this protocol is not fully specific for
Ehrlichia oxidized proteins (and therefore glycosylated proteins),
it is necessary to use a non-oxidized protein extracts to identify
false positive during the analysis (raw M/MS data available in
PRIDE archive ID: PXD012589). Proteins extracts (500 µg per
biological replicate) previously prepared in 2D-DIGE buffer were
first precipitated using the 2D Clean-up kit (GE Healthcare).
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Proteins were then solubilized using the coupling buffer NP40
[PBS with 1% Nonidet P-40 (NP40) and 0.1% SDS, pH 7.2],
using several cycles of sonication on ice, as described above.
The suspension was split in two for oxidative and non-oxidative
(control) sample preparation conditions. The control sample was
treated like the oxidized sample but without the addition of
sodium metaperiodate (NaIO4).
For the oxidation of the sugar moieties, 15 mM NaIO4 was
added to the solution, and proteins were incubated in the dark
for 30 min with end-over-end agitation. NaIO4 was removed
using microcon-10 kDa centrifugal unit (Millipore) and three
washing steps with NP40 buffer was made. A brief sonication
step on ice was made to reduce some protein aggregation.
Afterward, 250 µl of previously prepared ULH resin (Pierce) was
added, and the coupling reaction was shaken overnight at RT.
After coupling, beads were washed three times with 100 mM
Tris–HCl (pH 8) containing 2% sodium dodecyl sulfate (SDS)
and once with 50 mM NH4HCO3. Glycoproteins conjugated to
hydrazide beads were denatured by adding 8 M urea in 50 mM
NH4HCO3. Proteins were reduced by adding 100 mM DTT
with 1 h incubation at RT with agitation. After three washing
steps with 8 M urea in 50 mM NH4HCO3, the proteins were
alkylated by adding 50 mM IAA (prepared in 8 M urea in 50 mM
NH4HCO3) at RT and kept in dark for 30 min, with agitation.
Then, beads were washed three times with 50 mM NH4HCO3.
After washing, trypsin (Promega, Madison, WI, United States)
was added to the samples at a ratio of protein:trypsin 30:1,
and the samples were incubated at 37◦C for 18 h in 50 mM
NH4HCO3. The tryptic peptides were collected and desalted
with C18 zip-tips (Millipore). The beads were further washed
sequentially with 0.5% Triton X100 in 50 mM NH4HCO3,
5 M NaCl, 100 mM sodium carbonate (Na2CO3, pH 12), and
50 mM NH4HCO3 for three times. N-linked glycopeptides were
released by adding 2 µl of PNGase F (New England Biolabs,
Ipswich, MA, United States) and incubated at 37◦C overnight
with agitation. Deglycosylated peptides were also collected and
desalted with C18 zip-tip.
nLC-MS/MS Analysis
Peptides (from trypsin or PNGase F digestion) were analyzed
using a linear ion trap Velos-Orbitrap mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). Instrument
control was performed using Xcalibur software package,
version 2.2.0 (Thermo Fisher Scientific, Bremen, Germany).
Peptide mixtures were fractionated by on-line nanoflow
liquid chromatography using an EASY-nLC system (Proxeon
Biosystems, Thermo Fisher Scientific, Bremen, Germany)
with a two-linear-column system. Digests were loaded onto
a trapping guard column (EASY-column, 2 cm long, ID
100 µm, and packed with Reprosil C18, 5 µm particle size
from Proxeon, Thermo Fisher Scientific, Bremen, Germany)
at 4 µl/min. Then, samples were eluted from the analytical
column (EASY-column, 10 cm long, ID 75 µm, and packed
with Reprosil, 3 µm particle size from Proxeon, Thermo Fisher
Scientific, Bremen, Germany). Separation was achieved by
using a mobile phase from 0.1% FA (Buffer A) and 99.9%
ACN with 0.1% FA (Buffer B) and applying a linear gradient
from 0 to 35% of buffer B for 60 min for phosphopeptide
analysis and from 3 to 35% of Buffer B for 90 min for peptides
obtained from the glycoprotein enrichment analysis at a flow
rate of 300 nl/min. Ions were generated applying a voltage
of 1.9 kV to a stainless steel nano-bore emitter (Proxeon,
Thermo Fisher Scientific, Bremen, Germany), connected to
the end of the analytical column, on a Proxeon nano-spray
flex ion source.
The LTQ Orbitrap Velos mass spectrometer was operated
in data-dependent mode. A scan cycle was initiated with
a full-scan MS spectrum (from m/z 300 to 1600) acquired
in the Orbitrap with a resolution of 30,000. The 20 most
abundant ions were selected for collision-induced dissociation
fragmentation in the linear ion trap when their intensity exceeded
a minimum threshold of 1000 counts, excluding singly charged
ions. Accumulation of ions for both MS and MS/MS scans
was performed in the linear ion trap, and the AGC target
values were set to 1 × 106 ions for survey MS and 5000
ions for MS/MS experiments. The maximum ion accumulation
time was 500 and 200 ms in the MS and MS/MS modes,
respectively. The normalized collision energy was set to 35%,
and one microscan was acquired per spectrum. Ions subjected
to MS/MS with a relative mass window of 10 ppm were
excluded from further sequencing for 20 s. For all precursor
masses a window of 20 ppm and isolation width of 2 Da
were defined. Orbitrap measurements were performed enabling
the lock mass option (m/z 445.120024) for survey scans to
improve mass accuracy.
Data Processing
All raw files were searched against the UniprotKB ER database
(Bateman et al., 2017) (downloaded on January 2017 with 4148
entries and updated on December 2017) with MaxQuant version
1.5.5.1 [Max Planck Institute of Biochemistry (Cox and Mann,
2008)]. The parameters were set as follows:
(a) For phosphoproteome: search criteria included a
fixed carbamidomethylation of cysteines, and variable
modifications of oxidation on methionine residues,
and phosphorylation on serine, threonine, or tyrosine
residues were searched. Search was performed with trypsin
digestion and allowed a maximum of two missed cleavages
on the peptides analyzed from the sequence database.
The false-discovery rates (FDRs) of proteins, peptides,
and phosphosites were set at 0.01. The minimum peptide
length was seven amino acids, and a minimum Andromeda
score was set at 40 for modified peptides. A site localization
probability of 0.75 was used as the cutoff for localization
of phosphorylation sites. For advanced identification, the
Second Peptide Search (SPS) in MS2 spectra and the Match
Between Runs (MBR) feature were enabled.
(b) For whole proteome and glycoproteome: common search
criteria included a fixed carbamidomethylation of cysteines
and variable modifications of oxidation on methionine
residues. Search was performed with trypsin/P digestion
and allowed a maximum of two missed cleavages on the
peptides analyzed from the sequence database. The FDR
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from proteins and glycoproteins was set at 0.01. The
minimum peptide length was seven amino acids, and a
minimum Andromeda score was set at 40 for modified
peptides. For advanced identification, the SPS in MS2
spectra and the MBR feature were enabled.
(c) For N-glycoproteins: parameters were similar to
glycoproteomics (main search peptide tolerance: 4.5 ppm;
digestion: trypsin/P, max. 2 missed cleavages; fixed
modification: cysteines carbamidomethylation; variable
modification in the tryptic peptide fraction: methionine
oxidation, FDR set at 0.01, SPS and MBR were enabled).
For PNGase F fractions, variable modifications were:
methionine oxidation and asparagine deamidation. LFQ of
proteins with normalization was done in MaxQuant.
The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium1 via the PRIDE
partner repository (Vizcaíno et al., 2014) with the dataset
identifier “PXD012589”.
Bioinformatics
Known contaminants from MaxQuant database and reverse
identified peptides/proteins were discarded. All the statistical
analyses of the MaxQuant output tables were performed with
the Perseus program (version 1.5.6.0), which is a component of
the MaxQuant distribution. The tables were filtered to remove
contaminants and reversed sequences. Intensities were log(2)
transformed and the missing values of intensities were replaced
by normal distribution with a downshift of 1.8 SDs and a width
of 0.3 SDs. The differentially expressed proteins between ERGvir
and ERGatt were identified by the P-value (P < 0.05), which
is significant based on a two-sample t-test with a permutation-
based FDR cutoff 0.05 with S0 set on 0.2 for all data sets.
Furthermore, to identify N-glycosylated proteins, only
modified asparagines (N) within the canonical sequence
motif of N-glycosylation defined by the consensus motif
N–X–S/T (X = !P), were accepted as true glycosylation sites.
For identification of phosphorylation site motifs, we used
the Sequence Logos algorithm in Perseus. Predicted Gene
Ontology (GO) cellular functions of identified proteins with
high confidence from the two ER variants were obtained from
UniprotKB and using Perseus Annotation tools. Whenever an
identified protein had an unknown function and/or localization,
manual reannotation was performed using several databases
such as KEGG, Interproscan, etc.
Detection of O-Glycosylated Proteins
Using 2D Western Blotting Coupled to
MALDI–MS/MS
2D Gels Preparation
For protein isoelectric focusing (IEF), 50 µg of proteins (pool
of three ERGvir or ERGatt biological replicates described above)
was precipitated using 2D clean-up kit (GE Healthcare Bio-
sciences, Uppsala, Sweden). The pellet were resolubilized in
rehydration buffer (7 M urea, 2 M thio-urea, 4% CHAPS, 50 mM
1http://proteomecentral.proteomexchange.org
DTT, 0.5% IPG buffer pH 3–10 non-linear, 0.002% bromophenol
blue). To ensure a total solubilization of the proteins pellet,
sample was incubated at RT for 1 h, followed by homogenization
under vigorous agitation (vortex). The sample was applied on a
pre-cast immobilized pH gradient (IPG) strips (7 cm, pH 3–10,
non-linear, GE Healthcare Bio-sciences, Uppsala, Sweden) and
covered with mineral oil. Complete sample uptake was carried
out overnight for a passive rehydration at RT. Protein IEF was
carried out at 20◦C under a current limit of 75 µA per strip on
IPGphor3 cell (GE Healthcare Bio-sciences, Uppsala, Sweden)
and performed at 100 V for 1 h (Step mode), then 300 V for 2 h
(Gradient mode), followed by a ramping to 1000 V for 4 h and to
4000 for 3 h (Gradient mode), and was completed at 4000 V for
3 h (Step mode) for a total of 22,600 Vh (in 13 h).
After IEF, the IPG strips were equilibrated for 15 min at RT
under gentle agitation in reducing solution (50 mM Tris–HCl,
pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 0.002% bromophenol
blue; 2% w/v DTT). They were then equilibrated for a further
15 min in an alkylating solution, which was identical to the
reducing solution except that the DTT was replaced by 2.5%
(w/v) IAA. The equilibrated IPG strips were applied to the
top of a pre-cast acrylamide gel (pre-cast NuPAGE 4–12% Bis–
Tris Zoom, Invitrogen) and sealed with a concentrating agarose
solution (GE Healthcare Bio-sciences, Uppsala, Sweden) pre-
heated to 80◦C. Electrophoresis was carried out at 40 V, 400 mA,
and 50 W for 1 h and then at 100 V, 400 mA, 50 W for
3 h at RT with the XCell SureLockTM Mini-Cell Electrophoresis
System (Invitrogen) in running buffer (MES, Invitrogen). Once
electrophoretic separation achieved, gels were rinsed in ultrapure
water to remove the excess of SDS. After electrophoresis, gels
were used for total protein staining or western blotting as
described below.
Total levels of proteins were revealed using Colloidal
Coomassie Blue, according to methodology described by
Marcelino et al. (2015). Briefly, gels were stained for 24 h in
Colloidal Coomassie Blue and subsequently washed three times
in double distilled water. Gels were stored at 4◦C in a 20%
(w/v) ammonium sulfate solution until image acquiring and spot
excision. Digital images of the gels were acquired using a laser-
based scanner Typhoon FLA 9500 (GE Healthcare Bio-sciences,
Uppsala, Sweden).
Western Blot for O-GlcNAc Glycoprotein Detection
Western blotting was performed using the specific primary
antibody anti-O-GlcNAc monoclonal (MAb CTD 110.6) (Santa
Cruz Biotechnology, United States) as it is known to recognize
a wide range of O-GlcNAcylated proteins (Ma and Hart,
2014) and because there is no cross-reactivity with the
N-linked oligosaccharides.
After 2DE, proteins were transferred to a nitrocellulose
membrane, using the XCell IITM Blot Module (Invitrogen) at
30 V for 1 h. After the transfer, the membrane was stained
with Ponceau to ensure that the transfer was successful. After
several washing steps with milliQ water, the membrane was
blocked for 1 h at RT in Blocking buffer (Thermo Fisher), under
gentle agitation. Membrane was then incubated overnight at RT
with the specific primary MAb CTD 110.6 (diluted 1:200 in
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Blocking buffer) in a rocking platform. After several washing
steps with PBS-Tween 20 (PBS-T, 15-20 ml), the membrane
was incubated for 1 h at RT with HRP-conjugated secondary
antibody anti-mouse IgM-HRP (Thermo Fisher) (diluted 1:5000
in blocking buffer), in a rocking platform. After three washing
steps (10 min) with PBS-T, HRP subtract Peroxide solution and
Luminol solution was added at 1:1 ratio (0.12 ml of solution
per cm2 of the membrane). After 2 min incubation in the dark,
the excess of substrate was removed and the membrane was
put in the GE imager tray to detect the chemiluminescence in
automatic mode. Image capture of nitrocellulose membrane was
performed using ImageScanner III (GE Healthcare Bio-sciences,
Uppsala, Sweden).
Spot Picking and In-Gel Digestion
Spots identified as O-GlcNAc glycoproteins by western blot
were manually excised from a corresponding 2D gel stained
with Coomassie. Spots were excised with a 1000 µl tip and
transferred to a 96-well collecting plate containing 120 µl of a
10% ethanol solution. Plates with excised spots were stored at
−20◦C until further use.
The proteins of interest were digested into their component
peptides with trypsin and eluted from the gel plugs, as described
previously (Marcelino et al., 2015). Briefly, spots were excised,
destained, reduced with DTT, alkylated with IAA, and dried in
a speedvac. Gel pieces were rehydrated with digestion buffer
(50 mM NH4HCO3) containing trypsin (6.7 ng/µl) (Promega,
Madison, WI, United States) and incubated overnight at 37◦C.
The tryptic peptides were acidified with FA, desalted, and
concentrated using homemade reversed phase microcolumns
(POROS R2, Applied Biosystems, Foster City, CA, United States).
The peptides were eluted onto a MALDI plate using a matrix
solution that contained 5 mg/ml α-cyano-4-hydroxycinnamic
acid dissolved in 50% (v/v) ACN/0.1% (v/v) FA.
Protein Identification
Protein identification was undertaken on a 4800 MALDI-
TOF/TOF instrument (Applied Biosystems, Framingham, MA,
United States) with 4000 series explorer v3.5 software in both
MS and MS/MS mode. Each MS spectrum was obtained in a
result independent acquisition mode with a total of 800 laser
shots per spectrum, with internal calibration using Angiotensin II
(1046.2 Da), Angiotensin I (1296.5 Da), Neurotensin (1672.9 Da),
ACTH [1–17] (2093.5 Da), and ACTH [18–39] (2465.7 Da)
(PepMix1, from LaserBio Labs). Fifteen signal-to-noise (S/N)
best precursors from each MS spectrum were selected for
MS/MS analysis, starting with the most intense peak and
ending with the least intense peak. MS/MS analyses were
performed using Collision-induced dissociation (CID) assisted
with air, using a collision energy of 1 kV and a gas pressure
of 1 × 10−6 Torr. A total of 1400 laser shots were collected
for each MS/MS spectrum with the peak detection minimum
S/N setting at 20.
For protein identification in 2D gels, Mascot Generic Files
combining MS and MS/MS spectra were automatically created
and used to interrogate a non-redundant protein database using
a local version of Mascot v2.2 from Matrix Science through the
Global Protein Server (GPS) v3.6 (Applied Biosystems, Foster
City, CA, United States).
RESULTS
Phosphoproteome Characterization
The workflow for the analysis of phosphoproteome of ERGvir
and ERGatt is illustrated in Figure 1A. Three biological replicates
per ERGvir and ERGatt EBs were harvested at host cell lysis
and purified by a multistep centrifugation process as described
previously (Step 1). Proteins were extracted and peptides
generated using trypsin (Step 2). Phosphopeptides were enriched
(Step 3) and analyzed by nLC–MS/MS on a high-speed, high-
resolution mass spectrometer (Step 4). Peptide identifications
and protein expression analysis were done with MaxQuant
followed by Perseus analysis (Step 5). Tryptic peptides were also
used for proteome characterization, as described in Figure 1A.
This strategy led to identify with high confidence
(probability ≥ 0.75) a total of 92 phosphopeptides, representing
58 phosphoproteins common to both ERGvir and ERGatt
variants (Figures 2A,B and Supplementary Dataset S1).
Among the identified phosphoproteins, 22 proteins were
detected only in the phosphorylation data alone (Figures 2A,B
and Supplementary Datasets S1, S2), indicating that
phosphoproteins enrichment allowed detecting proteins that are
typically of low abundance (Park et al., 2015). Phosphoproteins
correspond to approx. 11% of the proteins identified in the global
proteome (n = 58/554 for ERGvir and n = 58/543 for ERGatt)
(Figures 2A,B and Supplementary Dataset S2).
Gene Ontology term analysis revealed that for both
ERGvir and ERGatt, 41% of the identified phosphoproteins
are membrane-associated (n = 24), 36% have unknown
cellular localization (n = 21), and 22% are cytosolic
(n = 13); no ribosomal phosphoproteins were detected
(Figure 2C). In the Top10 of the “biological process”
GO terms, 59% of the identified phosphoproteins were
found to have unknown function (n = 34/58); annotated
phosphoproteins span protein biosynthesis (n = 3), DNA
replication/repair/recombination/degradation (n = 3), amino
acid biosynthesis (n = 2), transport/virulence (n = 2), and cell
redox homeostasis (n = 2) (Figure 2D and Supplementary
Dataset S2). In both ERG variants, the two phosphoproteins
involved in virulence (proteins ERGA_CDS_03830 and
ERGA_CDS_04060) were homologous of AnkA and AnkB
virulence-associated proteins in A. phagocytophilum, respectively.
We also found the kinase pyruvate phosphate dikinase (Ppdk)
(which participated in pyruvate metabolic process) and
the phosphatase phosphatidylglycerophosphatase A (PgpA)
(involved in lipid metabolism).
We also investigated the relative abundance of
phosphorylation sites at serine, threonine, and tyrosine
residues. We found that serines (S) account for 43%, threonines
(T) for 34%, and tyrosines (Y) for 23% of all phosphorylation
sites (Figure 3A).
As the amino acids surrounding the phosphorylated residues
are important in determining the binding of a kinase to the
Frontiers in Microbiology | www.frontiersin.org 6 March 2019 | Volume 10 | Article 450
fmicb-10-00450 March 15, 2019 Time: 11:16 # 7
Marcelino et al. Modulation of E. ruminantium Biology by PTMs
FIGURE 1 | Overall workflow for integrated profiling of the proteomes, phosphoproteomes, glycoproteomes, and N-glycoproteomes of ERGvir and ERGatt.
Infectious ER EBs (three biological replicates per variant) were harvested at cell lysis, purified, and lysed for protein extraction. For proteome profiling, tryptic digestion
was performed (A). Part of the tryptic peptides were used for TiO2 enrichment for phosphoproteome profiling (A). For glycoproteome and N-glycoproteome profiling
(B), protein extracts were oxidized (highlighted in yellow) and incubated with ULH resin (non-oxidized sample was included as control to avoid for false-positive
identifications). All data were acquired with nLC–MS/MS and analyzed with MaxQuant and Perseus softwares.
protein sequence (of bacterial or host origin), we analyzed the
substrate-binding motifs in the ERG-phosphorylated peptides
(Figures 3B,C and Supplementary Dataset S1). Besides 18
phosphopeptides with unknown substrate motifs, we observed
that motifs matching those recognized by Casein Kinase II
(CKII), G protein-coupled receptor kinase 1 (GRK), CKI, and
PKA kinases (all being S/T kinases) (Pinna and Ruzzene, 1996)
are the most abundant one (Figure 3C and Supplementary
Dataset S1). None of these kinases were detected in ER proteome
(Supplementary Dataset S3).
We also found a high proportion of multiple phosphorylation
sites (2 and 3), in up to 66% of the identified phosphoproteins for
both variants (Figure 3D and Supplementary Dataset S1).
Differentially Expressed
Phosphoproteins
Label-free quantification of phosphoproteins was used to
identify differential phosphorylation events in virulent and
attenuated ER variants.
The heat maps in Figures 4A,B display proteins and
phosphoproteins (respectively) that were quantified in at least
two out of three biological replicates per variant and that passed
an ANOVA-based multisample test for statistically significant up-
or down-regulation, with a FDR of 5%. They allow visualizing
the experimental specificity between variants and reproducibility
within biological replicates: column-wise clustering of replicate
measurements demonstrated that inter-biological variation was
greater than intra-experimental variation. Proteins are color-
coded according to their MS signal intensities, which is a relative
measure for protein abundance (blue for increased abundance
and yellow for lowered abundance). The expression pattern of
identified proteins and phosphoproteins varies across the variants
reflecting the phenotypic differences of the ERG variants.
Quantitative analyses of ERG proteomes revealed that more
proteins are overexpressed in ERGvir (n = 113) compared to
ERGatt (n = 55) (FDR < 0.05 and S0 = 0.2) (Figure 4D
and Supplementary Dataset S3). In the phosphoproteome, we
quantified 21 and 1 phosphoproteins differentially expressed
(FDR < 0.05 and S0 = 0.2) in ERGvir and ERGatt, respectively
(Figure 4E and Supplementary Dataset S2).
Gene Ontology terms analysis of the unique phosphoprotein
overexpressed in ERGatt revealed that it is a membrane
protein with unknown function (Q5FFV9) (Supplementary
Dataset S2). The 21 phosphoproteins overexpressed in ERGvir
have unknown cellular localization (n = 10), are located in the
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FIGURE 2 | Characterization of ERGvir and ERGatt proteomes. (A) Number of identified proteins from proteome analysis (pink), phosphoproteome (green),
glycoproteome (yellow), and N-glycoproteome (blue) enrichments for the ERGvir and ERGatt variants. (B) Overlap between proteins in the global proteome,
phosphoproteome, and glycoproteome of ERGvir (green) and ERGatt (red). (C,D) Number of proteins identified in ERGvir (green) and ERGatt (red) in the global
proteomes, phosphoproteomes, and glycoproteomes that were localized in the indicated four major cellular components (C) and that were involved in Top10
biological processes (D), based on their GO.
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FIGURE 3 | Amino-acid sequence features of localized phosphorylation sites in ERG variants. (A) Percentages of serine (S), threonine (T), and tyrosine (Y)
phosphorylation sites identified. (B) Enriched phosphorylation motifs of bacterial phosphoproteomes obtained by Sequence logos analysis in Perseus software.
(C) Heat map visualizing relative abundance of sequence motifs matching the indicated kinases from phosphopeptides identified (row color bar highlight proteins
differentially expressed: blue, for increased abundance and yellow, for lower abundance). (D) Percentages of phosphopeptides single (_1), double (_2), and triply
phosphorylated (_3) (“multiplicity”).
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FIGURE 4 | Differential expression of proteins in the proteomes of ERGvir and ERGatt. (A–C) Unsupervised hierarchical clustering using Euclidian distance of the
proteome (A), the phosphoproteome (B), and the glycoproteome (C) data. Row color bar highlight proteins differentially expressed: blue, for increased abundance
and yellow, for lowered abundance. (D–F) The volcano plots representing the quantitative analyses of the proteome (D), the phosphoproteome (E), and the
glycoproteome (F) data. Significant changes in proteins, phosphoproteins, and glycoproteins in ERG were identified through a permutation-based FDR t-test
(FDR = 0.05; S0 = 0.2). All results are based on at least two of three measurements per variant. The significant up-regulated proteins in ERGvir are colored in green
and those in ERGatt, colored in red.
membrane (n = 6) or in the cytosol (n = 5) (Figure 5A and
Supplementary Dataset S2). In the Top10 Go terms analysis,
most of the overexpressed phosphoproteins in ERGvir have
unknown functions (n = 15); the “biological process” GO
terms associated with others cover glycolysis (n = 2/21) and
tricarboxylic acid cycle, DNA replication/repair/recombination,
and degradation of proteins (n = 3/21) (Figure 5B). Among
the most upregulated phosphoproteins are ERGA_CDS_00630,
ERGA_CDS_02510, and ERGA_CDS_04860 [all overexpressed
in ERGvir with fold change (FC) > log 2, Supplementary
Dataset S2]. All are uncharacterized proteins.
Glycoproteome Characterization
The workflow for the enrichment of glycoproteins is illustrated
in Figure 1B. ERGvir and ERGatt biological triplicates were
harvested at host cell lysis and EB were purified by a multistep
centrifugation process. After ERG lysis (Step 1), proteins extracts
were either oxidized or not with sodium meta-periodate (Step
2) and incubated with pre-prepared ULH resin (Step 3).
Glycoproteins were then enriched and two peptide fractions
derived from an on-bead tryptic digestion (tryptic peptides of
glycoproteins, TPG fractions) and a second fraction consisting
of PNGase F-released peptides (N-glycopeptides, NGP fraction)
(Step 4) were analyzed by LC–MS/MS for each biological sample
(Step 5). Peptide identifications and protein expression analysis
were done with MaxQuant followed by Perseus analysis (Step 6).
Combined, the analysis of TGP and NPG fractions resulted
in the identification of 371 and 343 annotated glycoproteins
detected in ERGvir and ERGatt datasets, including 64 and
36 variant-specific glycoproteins in ERGvir and ERGatt,
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FIGURE 5 | GO of the differentially expressed proteins of ERGvir and ERGatt proteomes, glycoproteomes, and phosphoproteomes. Number of proteins differentially
expressed identified in the global proteomes, phosphoproteomes, and glycoproteomes that were localized in the indicated four major cellular components (A) and
that were involved in Top10 biological processes (B), based on their GO.
respectively (Figures 2A,B and Supplementary Dataset S4).
This corresponds to 67% (n = 371/554) in ERGvir and 63%
(n = 343/543) in ERGatt of the total proteome. Among the
TPG fraction, 16 and 13 proteins were detected only in the
glycosylation dataset alone for ERGvir and ERGatt, respectively
(Figure 2A and Supplementary Dataset S4). In the NPG
fractions, only five proteins were detected confidently, three
being specific to ERGatt and two shared by both variants
(Figure 2A and Supplementary Dataset S4).
Gene Ontology term analysis of the identified proteins
indicated overall similar cellular component and biological
processes between ERGvir and ERGatt (Figures 2C,D).
Subcellular compartment analysis revealed that the identified
proteins are mainly located in the cytosol and in the membrane
(Figure 2C). In the Top10 “biological process” Go term, besides
the high number of uncharacterized glycoproteins (approx. 20%)
in both variants, we observed that the identified glycoproteins
are involved in several key biological processes such as protein
and amino acid biosynthesis and also virulence (such as VirB2,
VirB4, VirB6, VirB8, VirB9, VirB10, VirD4, AnkB AnkC,
ApxR, Ats-1, and Bax-1-related protein). Many ribosomal
proteins (n = 18) were detected in the glycoprotein fraction
(Supplementary Dataset S4). In the TPG fraction, we also
found 23 proteins that were detected in the ERGvir and ERGatt
phosphoproteomes: ERGA_CDS_00630, ERGA_CDS_02360,
ERGA_CDS_02470, ERGA_CDS_03680, ERGA_CDS
_04060, ERGA_CDS_04760, ERGA_CDS_05650, ERGA_CDS
_05790, ERGA_CDS_06390, ERGA_CDS_07690, ERGA_CDS_
08310, Map 1–3, Gap, GpmI, GrxC2, HflK, PccB, PheS, PpdK,
Thio, Tig, TktA, and Tld (Supplementary Dataset S2).
The identified N-glycoproteins (with the consensus sequence
N–X–S/T, X = !P) present in both variants include VirB6
(involved in virulence) and the chaperone GroES. Interestingly,
three additional N-glycoproteins were exclusively identified
in ERGatt: Ptr1 (involved in co-factor biosynthesis) and
two membrane-associated proteins, ERGA_CDS_05140 and
ERGA_CDS_02770 (Supplementary Dataset S5).
Differentially Expressed Glycoproteins
For label-free quantitative analysis, the proteomes of enriched
glycoproteins of ERGvir and ERGatt were compared. The heat
map in Figure 4C displays glycoproteins that were quantified
in the three biological replicates per variant and that passed
an ANOVA-based multisample test for statistically significant
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up- or down-regulation, with a FDR of 5%. Figure 4C also
shows that inter-biological variation was greater than intra-
experimental variation.
In the core glycoproteome, we quantified 31 and 8 proteins
with significant changes (FDR< 0.05 and S0 = 0.2) in ERGvir and
ERGatt, respectively (Figure 4F and Supplementary Dataset S4).
Subcellular compartment analysis revealed that up-regulated
glycoproteins in ERGvir are mainly located in the membrane
(52%, n = 16/31) or of unknown location (39%, n = 12/31),
while in ERGatt, the differentially expressed proteins are
mainly located in the cytosol (n = 6) (Figure 5A). Most
glycoproteins in ERGvir are of unknown function (n = 16)
compared to ERGatt (n = 1) (Figure 5B and Supplementary
Dataset S4). The Top10 “biological process” GO terms
associated with ERGvir and ERGatt glycoproteomes span
Transport/Virulence, DNA replication, repair, recombination
and degradation, and Stress response for both ERGvir and
ERGatt, whereas Glycolysis and Degradation of proteins are
only evidenced for ERGvir (Figure 5B). In ERGvir, the five
most upregulated glycoproteins (FC > log2) are proteins with
unknown function (ERGA_CDS_03680, ERGA_CDS_08310,
ERGA_CDS_03410) and with exonuclease function (PolA, Rnd)
(Supplementary Dataset S4). Proteins associated with virulence
in other Anaplasmatacae such as Ats-1, ApxR, VirB4, and VirB8
are also found to be overexpressed in ERGvir (Supplementary
Dataset S4). The glycoproteins NtrX (involved in transcription
regulation), ERGA_CDS_04560 (uncharacterized protein), VirB2
(virulence-associated protein), ThiC (Co-factor biosynthesis),
and FabI (Fatty acid biosynthesis) are overexpressed in ERGatt
(FC > log2) (Supplementary Dataset S4).
Identification of O-GlcNAcylated
Proteins
ERGvir and ERGatt protein extracts were separated by 2DE
and stained with SYPRO Ruby or transferred to a nitrocellulose
membrane and incubated with the monoclonal antibody CTD
110.6 (Figures 6A,B). Protein identification by MS revealed
that the most prominent spots corresponding to Map-1 protein
(spots 2, 3, 4, 5, 22, 23, 24, 25; Figure 6 and Supplementary
Dataset S6) are O-GlcNAcylated, in both variants. Other proteins
such as elongation factor Tu (spot 1), probable conjugal transfer
protein trbG (VirB9, spots 6 and 7), VirB11 protein (spot 8),
the porin ERGA_CDS_05140 (spot 9), ATP-dependent Clp
protease ATP-binding subunit ClpX (spots 10 and 11), and
Map1-1 protein (spot 13) were also found to be O-GlcNAcylated
FIGURE 6 | Detection of O-GlcNAcylated proteins in ERGvir (A) and ERGatt (B) using western blotting. 2D gels were used for western blotting (left) to detect
specifically O-GlcNAcylated proteins or were stained with Coomassie (right) to detect total proteins. Protein spots identified as O-GlcNAcylated proteins (blue circles,
in western blot) were excised from a corresponding 2D gels (yellow circles). Spots 14, 15, 16, and 17 (in ERGvir) and 31, 32, 33, and 34 (ERGatt) were only detected
in the 2D gel and were used as control (for non-O-GlcNAcylated proteins). Each gel and western blot is representative of ERGvir and ERGatt variants. The protein
identification for each spot is provided in Supplementary Dataset S6.
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in ERGvir (Figure 6A and Supplementary Dataset S6). In
ERGatt, proteins such as 60 kDa chaperonin (spots 12 and 18),
transcription termination/antitermination protein NusA (spot
19), cell division protein FtsZ (spots 20 and 21), elongation
factor Tu (spot 27), 50S ribosomal protein L25 (spot 28), peptide
deformylase (spot 29), and ATP-dependent Clp protease ATP-
binding subunit ClpX (spot 30) were found to be O-GlcNAcylated
(Figure 6A and Supplementary Dataset S6). All of these
proteins were detected in the TPG fraction (Supplementary
Dataset S4). These results suggest that most of the proteins
detected in the TPG fraction could be, in fact, O-GlcNAcylated
proteins (especially in the case of proteins that are simultaneously
phospho- and glycosylated, as reported above). To validate this
hypothesis, we also picked some spots that were present in
ERGvir and ERGatt 2D gels, but not in the western blot (Spots
14, 15, 16, and 17 for ERGvir; Spots 31, 32, 33, and 34 for ERGatt;
Figure 6). The mass spectrometry results indicated the presence
of GroEL, DnaK, rplL, ERGA_CDS_08670 proteins; these were
not detected in the TPG fraction (Supplementary Dataset S4)
but in the proteome (Supplementary Dataset S3). For the
GroEL protein, we noticed that although it was detected in the
TPG fraction, using western blotting, it was detected as non-
glycosylated in ERGvir (Figure 6A, spot 12) and O-glycosylated
in ERGatt (Figure 6B, spot 18).
DISCUSSION
Bacteria use PTMs to modify their own proteins [for adaptability
or cell cycle control (Grangeasse et al., 2015)], but also those
from the host to manipulate and regulate host processes and
hereby promote infection (Salomon and Orth, 2013). Herein,
we used an integrated proteomic approach to provide different
layers of protein information (including protein abundance and
PTMs) by analyzing the proteome, the S/T/Y phosphoproteome,
and glycoproteome (with O- and N-modifications) to identify
post-translationally modified proteins that could modulate ER
physiology and pathogenesis.
Ehrlichia ruminantium
Phosphoproteomics
A number of global phosphoproteome studies have now been
performed in bacteria, including E. coli, Helicobacter pylori,
Bacillus subtilis, Mycoplasma pneumoniae, Streptococcus
pneumoniae, Klebsiella pneumoniae, Lactococcus lactis,
Campylobacter jejuni, Pseudomonas sp. (Whitmore and
Lamont, 2012; Rioseras et al., 2018), and Chlamydia sp. (Claywell
et al., 2016). Nevertheless, the whole phosphoproteome of
Rickettsiales, and more specifically, Ehrlichia sp. has not been
mapped so far. Herein, we present the first phosphoproteomes
of two ER variants with different levels of virulence in vivo
and different cell culture behavior in vitro (Marcelino
et al., 2015). The annotated phosphoproteins are involved
in biological processes such as DNA recombination and repair,
cell metabolism, cell cycle and division, and also virulence
and are located in the membrane. Many identified proteins
remained uncharacterized, highlighting the need for further
studies on their function. Most importantly, the identified
phosphoproteins are present in both variants, indicating their
relevance in the physiology of the extracellular and infectious
form of the bacterium.
Protein phosphorylation plays a vital role in the
regulation of many cellular processes (such as central
carbon/protein/nucleotide metabolism, cell cycle, growth,
apoptosis, etc.) but also in the monitoring and adapting to the
dynamically changing environment in the host (Canova and
Molle, 2014). To rapidly adapt to these changes, the bacteria
can use environmental sensing systems such as two-component
systems (TCSs) (Wang, 2012; Mijakovic et al., 2016). Several
Rickettsiales (including ER) have the genes to code for three
histidine kinases (homologs of, PleC, CckA, and NtrY) and their
corresponding response regulators (homologs of PleD, CtrA,
and NtrX) (Cheng et al., 2006). Herein, in ERGvir and ERGatt
proteomes, we identified the response regulators NtrX, PleD,
and CtrA, but only the sensor protein PleC was detected. No
component of the TCS was found to be phosphorylated, neither
in ERGvir nor ERGatt. Only the protein ERGA_CDS_06790
with a GGDEF domain (often associated to a regulatory domain,
such as an oxygen sensing domain or a phosphorylation
receiver) was found to be phosphorylated. Interestingly, these
three pairs of TCSs were detected in A. phagocytophilum
and E. chaffeensis (using immunofluorescence labeling and
western blot analysis), but only during their intracellular
development (Cheng et al., 2006); this strongly suggests that
TCSs might be active mostly during the replicative phase
of the bacteria.
Nowadays, it is well recognized that besides the TCS, bacteria
can use, like eukaryotes, a network of protein phosphorylation
cascades that require the synchronized action of a number of
“eukaryote-like” serine/threonine and tyrosine kinases and their
associated phosphatases (Canova and Molle, 2014). While kinases
transfer a phosphate group from a nucleoside triphosphate
(usually ATP) and covalently attach it to specific amino acids
(such as S, T, and/or Y), phosphatases remove it. Kinases
and phosphatases act as on/off switches and hereby modulate
specific signal transduction pathways (Huse and Kuriyan, 2002).
According to Frutos et al. (2006), ERG genome contains
22 kinases and 6 phosphatases-coding genes (Frutos et al.,
2006) that could regulate phosphorylation events and, therefore,
would play an important role in the control of biological
processes such as proliferation, differentiation, and apoptosis.
In this work, we identified 13 kinases and 5 phosphatases
in the total proteome; among those, only pyruvate phosphate
dikinase and phosphatidylglycerophosphatase A were found to
be phosphorylated in ER EBs.
In bacteria, most phosphorylation sites are on Ser (70%)
and Thr (20%), while Tyr phosphorylation sites account
for less than 10% (Ge and Shan, 2011). A noteworthy
feature of ER EBs phosphoproteome is the significantly high
overall abundance (25%) of Tyr phosphorylation. To our
knowledge, there is only one bacterial phosphoproteome with
comparable Tyr phosphorylation percentage (K. pneumoniae,
25.8%) (Ge and Shan, 2011). Our results also show that
approx. 30% of the identified Tyr-phosphorylated proteins are
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overexpressed in ERGvir. Several studies have established that
Tyr phosphorylation is used as a key regulatory device of
bacterial physiology, linked to virulence, stress response, and
DNA metabolism (Grangeasse et al., 2015); this suggests that
ERGvir pathogenesis and virulence could be related to increased
levels of these Tyr-phosphorylated proteins. Tyr-phosphorylated
proteins have been found in other Anaplasmatacae: the above
mentioned, E. chaffeensis TRP47 (Wakeel et al., 2010) and
also, the ankyrin repeat protein of A. phagocytophilum, AnkA.
As for TRP47, AnkA was found to be Tyr-phosphorylated
after delivery into the leukocyte cytoplasm, suggesting a
tight interaction with the host (Ijdo et al., 2007; Lin et al.,
2007). In our work, we observed that ERGA_CDS_03830 and
ERGA_CDS_04060, the homologs of AnkA and AnkB virulence-
associated proteins, respectively, were phosphorylated on Ser
and Thr residues, respectively, instead of Tyr. Further studies
are required to elucidate the impact of such difference during
host cell infection.
Besides being specific to certain amino acids, kinases are
also quite discriminating in their preference for particular
peptides (Amano et al., 2015). In order to predict how well
any given (previously untested) peptide will be phosphorylated
by a given kinase, we analyzed the possible motifs of the
identified phosphopeptides using Perseus. As mentioned above,
the motifs matching those recognized by CKII, GRK, CKI, and
PKA kinases (all being S/T kinases) are the most abundant
ones in ER. None of these enzymes were detected in ER
proteome [or are present in the genome (Frutos et al., 2006)],
yet, they are present in the host (Bos taurus). This suggests
that ER could use these phosphopeptides to interact with its
host cell. As reviewed by Popa et al. (2016), some bacterial
proteins do not exhibit an enzyme activity when expressed in
bacterial systems, but rather require interaction with additional
eukaryotic factors for full activation. This might also be the
case for ER: indeed, for the ERG proteins to be targeted
(and thus, phosphorylated) by the host, the bacterial protein
should be exposed to the host environment during the infection,
namely in the form of reticulated bodies. As we used the
extracellular form of the bacterium as biological material, this
could explain also the low number of phosphorylated proteins
detected in this work.
Another interesting feature in the S/T/Y phosphoproteome of
ERG variants is the presence of multiple phosphorylation sites.
Phosphorylation at multiple sites within one domain or motif can
be used to fine-tune delicate micro-regulations of mechanisms
leading to pathogenesis, such as adhesion to and invasion of the
host cells, stimulation and regulation of pathogenic functions,
and weakening the host defense mechanisms (Ge and Shan,
2011). Our results revealed that ERG phosphopeptides have
multiple phosphorylation sites: 35 out of the 92 identified
phosphopeptides contain at least two phosphorylation sites.
Multiple phosphorylation sites have been also reported in the
characterization of the phosphoproteome of H. pylori and L. lactis
(as reviewed by Ge and Shan, 2011). As both have small genome
sizes, simple transcriptional machinery, and few sigma factors, it
was suggested that these two bacteria could use this molecular
strategy to perform delicate PTMs and hereby increase protein
functionality and/or signal fine tuning (Ge and Shan, 2011). As
ER has a comparable small genome, a similar regulation strategy
via multiple phosphorylation sites could have been developed
by this bacterium.
Ehrlichia ruminantium Glycoproteomics
Glycoproteome characterization has been achieved in several
bacteria, including the gastric pathogens H. pylori and C. jejuni
(Longwell and Dube, 2013), but has never been explored in
Rickettsiales. One of the most striking results obtained in this
work is the high percentage (up to 67%) of glycoproteins
detected in both variants. Our results show that ERGvir
glycoproteome is composed of 371 glycoproteins while ERGatt
has 343. These glycoproteins are involved in key biological
processes such as protein, amino-acid and purine biosynthesis,
translation, virulence, DNA repair, and replication. Among the
proteins that constitute the core glycoproteome (307), only
2% are up-regulated in ERGatt while 10% are overexpressed
in ERGvir. These include virulence-associated proteins such as
VirB10, VirB2, VirB4, VirB6, VirB8, VirB9, VirD4, AnkB, AnkC,
ApxR, Ats-1, and Bax-1-related protein. Protein glycosylation
in bacteria has shown not to be vital for growth in laboratory
conditions, yet it is essential in pathogenic bacteria (Poole et al.,
2018) and this could explain why ERGvir has more specific
proteins and higher expression levels of glycosylated proteins
compared to ERGatt. Unfortunately, many proteins of potential
interest with differential expression levels are of unknown
function, and deserve further investigation to determine their
functional role in the bacterial virulence.
Protein glycosylation is the process by which a carbohydrate
is covalently attached to a protein on an asparagine (Asp, N)
to form an N-linked glycan, or to serine (Ser, S) and threonine
(Thr, T) residues to form an O-linked glycan (Valguarnera
et al., 2016). In bacteria, O-glycosylation appears as a widespread
phenomenon, while N-glycosylation of proteins seems to be more
restricted (Dell et al., 2010), and our results demonstrated that it
is the case also for ER. Indeed, while only five N-glycoproteins
were identified in ERG variants, we detected at least 12
O-GlcNAcylated proteins per variant using 2D western blotting.
Glycans serve a variety of structural and functional roles
in membrane and secreted proteins. For instance, they may
contribute to modulate immune responses and to impact
processes such as adhesion or invasion (Valguarnera et al., 2016;
Stadlmann et al., 2017; Veillon et al., 2017). In ERG, approx.
35% of the identified glycoproteins are membrane-associated. Of
particular interest are the proteins from the Map-1-family and the
porin ERGA_CDS_05140 (“porin 5140”). These outer membrane
proteins are the most abundant proteins in the ERG and present
numerous proteoforms: 36 for Map-1 and 27 for porin 5140
(Marcelino et al., 2015). Map-1 is known to induce a strong
immune response in the host, but its precise role in protective
immunity against heartwater is not fully understood. Using
2D western blot, four different spots corresponding to Map-1
were detected in each variant and were positively identified as
O-GlcNAcylated proteins. Different spots for the same protein
might correspond to slight differences in glycan composition,
that could affect Map-1 recognition by the host receptor, leading
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to a reduced (or impaired) inflammatory response in vivo. This
strongly suggest that Map-1 protein could be used to trick the
host immune system, as suggested elsewhere (Marcelino et al.,
2015). Further studies regarding the characterization of the
glycan associated to Map-1 should be performed to elucidate
this hypothesis. Porin_5140 was found to be glycosylated in
both ERGvir and ERGatt; still, in ERGatt, glycan is linked
to Asparagine and therefore is N-glycosylated while in the
virulent variant porin 5140 was found to be O-GlcNAcylated.
The biological implication of this difference deserves further
studies. As mentioned above, glycosylation has been detected
on Ehrlichia and Anaplasma outer membrane proteins and
TRPs. For instance, E. chaffeensis (TRP120 and TRP156) and
E. canis (p140) proteins (McBride et al., 2000) were found to be
glycosylated. A. marginale major surface protein 1 (MSP1) and
2 (MSP2) are glycosylated adhesins, involved in the attachment
to vector and/or host cells, and could mimic lectins (De la
Fuente et al., 2001; Garcia-Garcia et al., 2004; Dinglasan and
Jacobs-Lorena, 2005). Our results suggest that ER could have
developed comparable strategies (mimicry of lectins) to attach to
the host cell target.
Anaplasmatacae utilize the bacterial Type IV secretion system
(T4SS) to subvert the host innate immune system and exploit
the host cell. The T4SS system is a multi-component membrane-
spanning transporter machinery that translocates DNA to or
from bacteria, and proteins or nucleoprotein complexes to the
eukaryotic target cells (Alvarez-Martinez and Christie, 2009).
Here, several “building blocks” of the ER T4SS such as VirB2
(homolog VirB2-8), VirB4, VirB6, VirB8, VirB9, and VirD4
protein were detected in ER glycoproteome. In the literature,
the VirB10 protein was found to be N-glycosylated in C. jejuni
(Nothaft and Szymanski, 2013); to our knowledge, no further
information regarding the glycosylation of the T4SS components
was found. Manual reannotation of proteins led us to identify ER
bacterial effectors homologous to A. phagocytophilum proteins
in the TPG fraction such as T4SS-secreted proteins AnkB,
AnkC, Ats-1, and AprX proteins. We also identified a Bax
inhibitor (BI)-1 like protein in ER glycoproteome. Ats-1-
and BI-1-like protein are known to interfere with host cell
apoptosis, and ApxR- and Ank-related proteins can regulate
gene expression (Wang et al., 2007). These proteins could
be used by ER to avoid death of the host cell during the
infection process and to subvert the cell metabolism to its
benefit and growth.
Protein glycosylation relies on glycosyltransferases activity
to catalyze the transfer of an activated donor sugar to an
appropriate acceptor, typically another sugar, lipid, protein,
or small molecule. Despite all the glycoproteins detected in
this work, according to bioinformatics analysis of Ehrlichia
genomes, there is no evidence for the presence of conserved
glycosyltransferases (Cantarel et al., 2009). Still, the possibility
of the existence of a novel glycosyltransferase in the genome
of ER should not be ruled out (Cheng et al., 2006). Members
of the Anaplasmataceae family are enveloped with a rippled
thin outer membrane which lacks thickening of the inner or
outer leaflet and shows no sign of a peptidoglycan layer or
lipopolysaccharide (LPS) (as reviewed in Lin and Rikihisa, 2003).
This again emphasizes the poor ability of Ehrlichia species
to produce glycans. Nevertheless, both the host (B. taurus)
(Cantarel et al., 2009) and the vector (Amblyomma ticks)
(Natala et al., 2013) have glycosyltransferases (GT19, 28, and
30). This result again emphasizes the intimate relation between
Ehrlichia and its host (and/or vector) as the bacterium could take
advantage of the host and/or vector PTMs machinery for its own
proteins modification.
PTMs Crosstalk in Ehrlichia ruminantium
In eukaryotes, the reversible modification of nuclear and
cytoplasmic proteins with β-O-GlcNAc is important for
transcriptional regulation, signaling, and protein–protein
interactions, as mentioned above. Additionally, multiple
PTMs have been documented to exist on the same protein,
revealing an additional level of complexity (named “PTMs
crosstalk”) (Hao et al., 2011; Leney et al., 2017). Due to the
biosynthetic complexity of O-glycosylation, and contrary to
N-glycoprotein detection, there are no consensus sequence
motifs that can be used to predict and identify O-glycoproteins.
Herein, based on the results obtained with immunodetection,
we hypothesized that most of the proteins identified in the
TPG are O-GlcNAcylated. Moreover, we also detected 23
proteins being both phosphorylated and glycosylated. This
feature could explain why few phosphorylated proteins
were detected in ERG, in particular ribosomal protein.
Indeed, sites of O-GlcNAcylation are often found at or
in close proximity to protein phosphorylation sites, and
the intricate interplay (“PTMs crosstalk”) between both
modifications is known to modulate many important
processes in cells. Our results suggest that ER EBs use
O-GlcNAcylation and phosphorylation as a major cellular
signaling mechanism which could be primed for metabolism
upon entry into the host cell.
CONCLUSION AND PROSPECTS
This work strengthens previous reports on the existence of
post-translationally modified proteins by glycosylation and
phosphorylation in Rickettsiales. It also confirms that Ehrlichia
uses these PTMs to generate multiple expressed protein forms
and exploit them as regulatory devices to adapt itself to the
different hostile environments encountered during its complex
life cycle (mammalian and tick cells).
Most bacterial PTMs are dynamic and reversible. As such, we
believe that the phosphoproteome presented herein is likely to be
underrepresented, as phosphoproteomes are very dynamic. For
instance, we speculate that Ehrlichia phosphoproteome would
vary between early, middle, and late bacterial growth stages
to accomplish the physiological needs of each developmental
stage, and could represent a new way for selecting key
molecular elements for the bacterium survival. We suggest
that, while extracellular non-metabolically active EBs have
reduced amount of phosphorylated proteins, these could be
phosphorylated by interchange with O-GlcNAcylated within the
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host cell. More information about Ehrlichia phosphoproteome
and the correlation between bacterial phosphorylation and
potential pathogenicity will surely contribute to develop
protein phosphorylation-targeted prodrugs for the control of
bacterial infections.
The precise functions of bacterial glycoproteins in
bacterial survival and adaptation and within host–pathogen
interaction are just starting to arise. Understanding these roles
represents new opportunities in the prevention of bacterial
infections; this is of key importance especially when antibiotic
resistance continues to increase. Indeed, bacterial glycoproteins
represent attractive targets for new antibacterial treatments,
as they are frequently linked to pathogenesis and contain
distinctive glycans2 that are absent in mammalian hosts. The
emerging studies of bacteria glycoprotein pathways enable
setting the stage for the development of glycosylation-based
therapeutic strategies, such as glycan-based vaccines to treat
or prevent bacterial infection, especially to circumvent the
use of antibiotics. Furthermore, as glycosyltransferases have
not been identified in Ehrlichia sp. genomes, additional
studies should be performed to define the mass of these
glycoproteins; this would contribute to understand the
extent and nature of the glycans (composition, structure,
and attachment sites) on both the (native or recombinant)
glycosylated proteins.
Globally, the data set reported herein represents groundwork
and provides a useful resource for further hypothesis-driven
studies of Ehrlichia-specific variations in phosphorylation and
especially glycosylation-mediated regulation of proteins. It also
opens a window of opportunity to identify new cellular targets
for regulatory events.
2 http://csdb.glycoscience.ru/bacterial/
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